Tower Research Capital LLC (Trc) Ginkgo Bioworks Holdings, Inc. Transaction History

Tower Research Capital LLC (Trc)

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.28 - $1.16 $6,266 - $25,961	22,381 Added 18.23%	145,120 $47,000
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $324,515 - $511,265	-306,147 Reduced 71.38%	122,739 $142,000
Q4 2023 Feb 13, 2024	BUY	$1.26 - $1.79 $511,891 - $727,210	406,263 Added 1795.8%	428,886 $724,000
Q3 2023 Nov 14, 2023	SELL	$1.61 - $2.54 $9,202 - $14,518	-5,716 Reduced 20.17%	22,623 $40,000
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $146,191 - $250,064	-128,238 Reduced 81.9%	28,339 $52,000
Q1 2023 May 09, 2023	SELL	$1.2 - $2.19 $46,227 - $84,365	-38,523 Reduced 19.75%	156,577 $208,000
Q4 2022 Feb 10, 2023	SELL	$1.63 - $3.52 $30,378 - $65,602	-18,637 Reduced 8.72%	195,100 $330,000
Q3 2022 Nov 10, 2022	BUY	$0.73 - $3.74 $90,078 - $461,497	123,395 Added 136.59%	213,737 $667,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $194,682 - $371,666	88,492 Added 4783.35%	90,342 $215,000
Q1 2022 May 12, 2022	BUY	$2.83 - $8.69 $1,698 - $5,214	600 Added 48.0%	1,850 $7,000
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $4,570 - $8,206	550 Added 78.57%	1,250 $10,000
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $6,405 - $9,296	700 New	700 $8,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.